Prostate biopsy
ProcedureTransperineal prostate biopsy
NCT Number: NCT06986083
The purpose of this study is to look whether using local anesthesia during a transperineal prostate biopsy, while put to sleep by IV sedation, helps reduce the number of people who feel significant pain in the recovery room. The researchers will also look at how local anesthesia affects the amount of pain medication used, how quickly people can go home after the biopsy, and how well they recover after leaving the hospital.
Interested in participating?
Request Info18 year and older
Male
Interventional
Phase 3
Memorial Sloan Kettering Cancer Center at Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Local anesthesia versus no local anesthesia during transperineal biopsy, while the patient is under IV sedation:
Standardization of a periprocedural pathway versus usual care for focal gland ablation:
Exclusion criteria
Local anesthesia versus no local anesthesia during transperineal biopsy, while patient is under IV sedation:
Standardization of a periprocedural pathway versus usual care for focal gland ablation:
Transperineal prostate biopsy
Local anesthesia in addition to IV sedation
Time frame: up to 1 day
defined as at least one pain score ≥ 5 on a 0 - 10 scale in the post anesthesia care unit (PACU)
Contact information is provided by the study sponsor or research team.
Behrar Ehdaie, MD, MPH
CONTACT
Jonathan Fainberg, MD, MPH
CONTACT
Memorial Sloan Kettering Cancer Center
Other
A Randomized Controlled Trial of Modifications to Prostate Needle-Based Procedures
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06625970
Genital Diseases, Genital Diseases, Male
Brest, France
View Trial DetailsNCT06954337
Breast Cancer, Breast Diseases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT02960022
Genital Diseases, Genital Diseases, Male
Anchorage, Alaska, United States
View Trial DetailsNCT07005154
Genital Diseases, Genital Diseases, Male
Huntsville, Alabama, United States
View Trial Details